drugset / Trial / NCT00696774

Switching to Duloxetine in Patients With Depression

NCT00696774

Phase 4 Completed 242 enrolled Eli Lilly and Company
Parallel-groupOpen-labelTreatment

Summary

The purpose of this study is to help answer the following research question: Whether switching to duloxetine improves depressed mood when current treatment did not work well for patients with depression.

Timeline

Start
2008-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg
Subject Duloxetine Small molecule 120 mg